Novo Nordisk A/S is poised for long-term growth despite job cuts and margin resets. Click here to find out why NVO stock is a ...

The rapid rise in prescriptions for GLP-1 weight loss drugs had a muted effect on Delaware health insurers’ spending thanks ...

CVS Caremark is facing a lawsuit after being accused of pointing patients to use a weight loss drug called Wegovy and for ...

As evidence grows supporting the potential health benefits of obesity drugs like Novo Nordisk’s Wegovy and Eli Lilly & Co.’s ...

The post As Insurers Struggle With GLP-1 Costs, Some Seek To Wean Patients Off appeared first on Katie Couric Media. Innotox is like Botox, but without FDA approval or a whole lot of other important ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

Critical decisions are too often made not by doctors in consultation with their patients, but behind closed doors between ...

As people come off GLP-1 medications like Ozempic and Wegovy, Virtua Health and other companies are pushing behavior-based weight management programs.

A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. | A new ...

A class-action lawsuit filed against CVS Caremark argues that the PBM dropping coverage of Zepbound for Wegovy is illegal.

Two New York residents have filed a lawsuit against CVS after the company’s pharmacy benefit manager, Caremark, denied coverage for Zepbound in favor of Wegovy. The plaintiffs — Dennis Larkin of ...